期刊文献+

同位素标记示踪法测定G蛋白竞争性抑制肽-27在动物体内的分布与排泄

Isotope tracer labelling method for determination of distribution and excretion of GCIP-27
下载PDF
导出
摘要 目的:利用同位素标记示踪法研究G蛋白竞争性抑制肽(GCIP)-27在动物体内的分布和排泄。方法:125I-GCIP采用Iodogen法标记,按组织器官直接测定法和TCA沉淀法进行体内分布实验,以每毫克组织器官的125I-GCIP放射性计数表示GCIP在小鼠体内的分布;以不同时间段大鼠胆汁、尿、粪及小鼠的尿、粪放射性总排泄量占给药量放射性的百分比表示其在体内的排泄。结果:GCIP-27在小鼠体内分布广泛,其中肾、血管、胃、肺、心、小肠等组织分布较高,肌肉、脂肪等组织相对较低,脑最低。大鼠72h粪、尿、胆汁原形药物排泄量分别为给药量的26.13%,0.95%和4.12%。小鼠72h粪、尿原形药物排泄量分别为给药量的27.92%,0.84%。结论:GCIP-27在小鼠体内广泛分布,主要经尿液排泄,肾为主要排泄器官。 OBJECTIVE To study the distribution and excretion of GCIP-27 (G protein inhibitory polypeptide-27) in anirnals.METHODS ^125I-GCIP-27 was prepared by Iodogen method, the distribution and excretion were measured by direct assay and trichloroacetic acid (TCA) precipitation method after iv ^125I-GCIP. RESULTS GCIP-27 was shown to be widely distributed to the various tissues. There was a relatively higher in kidney, blood vessel, stomach, lung, heart, mall intestine and so on, and relatively lower in fat and muscle,and the lowest in brain. GCIP-27 excreted in urine,feces and bile within 72 h was 26. 13%,0. 95% and 4. 12% in rats respectively,and urine,feces within 72 h was 27. 92% ,0. 84% in mice respectively. CONCLUSION The distribution of GCIP-27 is extensive and the parent compound was mainly excreted by urine,and,kidney is main emunctory.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2008年第4期256-259,共4页 Chinese Journal of Hospital Pharmacy
基金 重庆市自然科学基金重点攻关课题(项目编号:20048256,20027537,20010725)
关键词 G蛋白竞争性抑制肽 同位素标记示踪法 三氯醋酸沉淀法 GCIP-27 isotope tracling method TCA precipitation method
  • 相关文献

参考文献7

二级参考文献33

  • 1张丹参,张力,薛贵平,王树.大黄酚的抗衰老作用[J].中国医院药学杂志,2005,25(1):18-20. 被引量:25
  • 2庞志功,汪宝琪.大黄素大黄酚在兔体内药代动力学的研究[J].西安医科大学学报,1993,14(4):346-349. 被引量:19
  • 3周晓莉,雷寒,柳青.血管平滑肌细胞的培养及鉴定[J].重庆医学,2005,34(6):877-878. 被引量:32
  • 4周继红,袁倚盛,杨俊伟.高效薄层色谱法测定血清中大黄有效成分的含量[J].药物分析杂志,1995,15(6):36-39. 被引量:24
  • 5王鸿利.大黄有效单体止凝血机理的临床研究[J].中西医结合杂志,1985,5(9):555-555.
  • 6[1]Copper G 4th. Basic determinants of myocardial hypertrophy: a review of molecular mechanisms[J]. Annu Rev Med, 1997, 48: 13-23.
  • 7[2]Scheuer J. Catecholamines in cardiac hypertrophy[J]. Am J Cardiol, 1999, 83(12A): 70H-74H.
  • 8[3]Akhter S A, Luttrell L M, Rockman H A, et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy[J]: Science, 1998, 280(5363): 574-577.
  • 9[4]Eckhart A D, Duncan S J, Penn R B, et al. Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart[J]. Circ Res, 2000, 86(1): 43-50.
  • 10[5]Zolk O, Kouchi I, Schnabel P, et al. Heterotrimeric G proteins in heart disease[J]. Can J Physiol Pharmacol, 2000, 78(3): 187-198.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部